Bosh sahifaEWL • ETR
add
Edwards Lifesciences Corp
Yopilish kursi
69,07 €
Kunlik diapazon
68,99 € - 69,66 €
Yillik diapazon
54,00 € - 88,64 €
Bozor kapitalizatsiyasi
41,45 mlrd USD
Oʻrtacha hajm
552,00
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
NYSE
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Daromad | 1,35 mlrd | 8,93% |
Joriy xarajat | 697,20 mln | 11,61% |
Sof foyda | 3,07 mlrd | 697,82% |
Sof foyda marjasi | 226,73 | 632,33% |
Har bir ulushga tushum | 0,67 | 13,56% |
EBITDA | 428,80 mln | 5,88% |
Amaldagi soliq stavkasi | 10,10% | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 4,45 mlrd | 138,54% |
Jami aktivlari | 12,97 mlrd | 38,42% |
Jami passivlari | 3,36 mlrd | 27,09% |
Umumiy kapital | 9,61 mlrd | — |
Tarqatilgan aksiyalar | 589,80 mln | — |
Narxi/balansdagi bahosi | 4,27 | — |
Aktivlardan daromad | 8,55% | — |
Kapitaldan daromad | 10,65% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | sen, 2024info | Y/Y qiyosi |
|---|---|---|
Sof foyda | 3,07 mlrd | 697,82% |
Operatsiyalardan naqd pul | 351,80 mln | -14,51% |
Sarmoyadan naqd pul | 2,70 mlrd | 2 935,62% |
Moliyadan naqd pul | -976,70 mln | -581,58% |
Naqd pulning sof oʻzgarishi | 2,03 mlrd | 452,76% |
Boʻsh pul | 1,23 mlrd | 378,57% |
Haqida
Edwards Lifesciences is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the SAPIEN transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; the Dominican Republic; Puerto Rico; and Singapore; and is building a new facility due to be completed in 2021 in Limerick, Ireland. Wikipedia
Tashkil etilgan
1958
Sayt
Xodimlar soni
19 800
